Bank Of New York Mellon Corp Biomea Fusion, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$6.8 - $32.35 $103,094 - $490,458	15,161 New	15,161 $470 Million
Q2 2022 Aug 15, 2022	SELL	$3.0 - $12.03 $150,951 - $605,313	-50,317 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$4.39 - $9.03 $24,794 - $51,001	5,648 Added 12.64%	50,317 $225,000
Q4 2021 Feb 11, 2022	BUY	$7.22 - $12.72 $191,618 - $337,588	26,540 Added 146.4%	44,669 $332,000
Q3 2021 Nov 12, 2021	BUY	$10.0 - $15.99 $38,800 - $62,041	3,880 Added 27.23%	18,129 $217,000
Q2 2021 Aug 11, 2021	BUY	$13.65 - $20.93 $194,498 - $298,231	14,249 New	14,249 $222,000

104

17.8M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $124M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.